PBE Holdings List

As of Aug 12, 2025

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	7.25%	38,372
2	ILMN	Illumina, Inc.	5.77%	134,951
3	GILD	Gilead Sciences, Inc.	5.38%	102,043
4	RPRX	Royalty Pharma plc	5.37%	340,533
5	AMGN	Amgen Inc.	4.99%	39,835
6	BMRN	BioMarin Pharmaceutical Inc.	4.79%	191,568
7	UTHR	United Therapeutics Corporation	4.68%	35,357
8	VRTX	Vertex Pharmaceuticals Incorporated	4.25%	24,958
9	AVXL	Anavex Life Sciences Corp.	3.90%	823,883
10	COLL	Collegium Pharmaceutical, Inc.	3.43%	205,970
11	INCY	Incyte Corporation	3.33%	92,916
12	HALO	Halozyme Therapeutics, Inc.	3.14%	111,578
13	PTGX	Protagonist Therapeutics, Inc.	3.13%	130,779
14	ARWR	Arrowhead Pharmaceuticals, Inc.	3.09%	395,058
15	ACAD	ACADIA Pharmaceuticals Inc.	3.06%	273,639
16	FOLD	Amicus Therapeutics, Inc.	2.98%	973,079
17	QGEN	Qiagen N.V.	2.98%	138,471
18	DVAX	Dynavax Technologies Corporation	2.89%	620,860
19	NBIX	Neurocrine Biosciences, Inc.	2.80%	49,511
20	VCYT	Veracyte, Inc.	2.74%	217,091
21	RGEN	Repligen Corporation	2.64%	49,552
22	PTCT	PTC Therapeutics, Inc.	2.52%	126,870
23	EXEL	Exelixis, Inc.	2.35%	140,914
24	MNKD	MannKind Corporation	2.32%	1,443,999
25	CPRX	Catalyst Pharmaceuticals, Inc.	2.18%	244,444

As of Aug 12, 2025